Kling, Biotherapeutics

Kling Biotherapeutics Strengthens Leadership Team to Advance Pipeline Using its Proprietary Primary B-Cell Selection and Evolution Platform

Published on 08/07/2025 at 18:04 | prnewswire.co.uk

Kling Biotherapeutics Netherlands

Alessandra Micaela Villa appointed Director of Platform DevelopmentRob Roovers appointed Director of Preclinical DevelopmentView original content:https://www.prnewswire.co.uk/news-releases/kling-biotherapeutics-strengthens-leadership-team-to-advance-pipeline-using-its-proprietary-primary-b-cell-selection-and-evolution-platform-302326485.html

en | boerse | 67983002 |